Literature DB >> 2521927

Down patients: extracellular preamyloid deposits precede neuritic degeneration and senile plaques.

G Giaccone1, F Tagliavini, G Linoli, C Bouras, L Frigerio, B Frangione, O Bugiani.   

Abstract

Using anti-SP28 (a polyclonal antibody to a 28 residue synthetic peptide homologous to the NH2-terminal region of the Alzheimer amyloid beta-protein) to investigate the cerebral cortex of 6 Down patients aged 6-55 y, we found that, besides senile plaques and congophilic vessels, extracellular deposits unrelated to degenerating neurites, tangle-bearing neurons or congophilic vessels were labelled. These deposits were similar to the extracellular deposits previously observed in the cerebral cortex of Alzheimer patients and non-demented individuals. The material accumulated in the deposits did not react with Congo red, thioflavine S or, on some occasions, silver salts and therefore might have been constituted by beta-protein precursors lacking the molecular conformation of amyloid fibrils. Age-related analysis of the cortical lesions in Down patients suggested that such extracellular deposits precede degenerating neurites and evolve into senile plaques.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2521927     DOI: 10.1016/0304-3940(89)90169-9

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  53 in total

1.  Epitope map of two polyclonal antibodies that recognize amyloid lesions in patients with Alzheimer's disease.

Authors:  J Ghiso; T Wisniewski; R Vidal; A Rostagno; B Frangione
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

2.  Phagocytosis and deposition of vascular beta-amyloid in rat brains injected with Alzheimer beta-amyloid.

Authors:  S A Frautschy; G M Cole; A Baird
Journal:  Am J Pathol       Date:  1992-06       Impact factor: 4.307

3.  Stimulated platelets release amyloid beta-protein precursor.

Authors:  G M Cole; D Galasko; I P Shapiro; T Saitoh
Journal:  Biochem Biophys Res Commun       Date:  1990-07-16       Impact factor: 3.575

4.  Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's disease.

Authors:  L M Bekris; N M Galloway; S Millard; D Lockhart; G Li; D R Galasko; M R Farlow; C M Clark; J F Quinn; J A Kaye; G D Schellenberg; J B Leverenz; P Seubert; D W Tsuang; E R Peskind; C E Yu
Journal:  Neurobiol Aging       Date:  2010-12-31       Impact factor: 4.673

5.  Demonstration of amyloid beta-protein in a 32-year-old man with progressive dementia.

Authors:  D C Guiroy; P P Liberski; J Alwasiak; W Papierz; D C Gajdusek
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

6.  Deposition of amyloid beta protein in non-Alzheimer dementias: evidence for a neuronal origin of parenchymal deposits of beta protein in neurodegenerative disease.

Authors:  D M Mann; D Jones; P W South; J S Snowden; D Neary
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

Review 7.  Genetics of Alzheimer disease.

Authors:  Lynn M Bekris; Chang-En Yu; Thomas D Bird; Debby W Tsuang
Journal:  J Geriatr Psychiatry Neurol       Date:  2010-12       Impact factor: 2.680

8.  Amyloid beta peptide potentiates cytokine secretion by interleukin-1 beta-activated human astrocytoma cells.

Authors:  B D Gitter; L M Cox; R E Rydel; P C May
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

9.  Early Alzheimer disease-like histopathology increases in frequency with age in mice transgenic for beta-APP751.

Authors:  L S Higgins; J M Rodems; R Catalano; D Quon; B Cordell
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

10.  Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia.

Authors:  D Giulian; L J Haverkamp; J H Yu; W Karshin; D Tom; J Li; J Kirkpatrick; L M Kuo; A E Roher
Journal:  J Neurosci       Date:  1996-10-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.